Stacie Shepherd's Colleagues at QED Therapeutics
Stacie Shepherd's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Stacie Shepherd's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Stacie Shepherd
Stacie Shepherd currently works for QED Therapeutics.
Stacie Shepherd's role at QED Therapeutics is SVP, Clinical Development.
Stacie Shepherd's email address is ***@qedtx.com. To view Stacie Shepherd's full email address, please signup to ConnectPlex.
Stacie Shepherd works in the Biotechnology industry.
Stacie Shepherd's colleagues at QED Therapeutics are Todd Bobick, Mar Reyes, Lihua Zhang, Brian Eater, Yen Nguyen, Andrea Orozco, Adalynn Harris and others.
Stacie Shepherd's phone number is 650-231-4088